NO126272B - - Google Patents
Download PDFInfo
- Publication number
- NO126272B NO126272B NO02833/68A NO283368A NO126272B NO 126272 B NO126272 B NO 126272B NO 02833/68 A NO02833/68 A NO 02833/68A NO 283368 A NO283368 A NO 283368A NO 126272 B NO126272 B NO 126272B
- Authority
- NO
- Norway
- Prior art keywords
- formula
- triazine
- compound
- amino
- acid
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 41
- 150000001875 compounds Chemical class 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 9
- 150000001412 amines Chemical class 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 150000003918 triazines Chemical class 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 230000001077 hypotensive effect Effects 0.000 claims description 3
- 239000012442 inert solvent Substances 0.000 claims description 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
- 208000001953 Hypotension Diseases 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 230000001882 diuretic effect Effects 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 208000021822 hypotensive Diseases 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- 239000002904 solvent Substances 0.000 description 20
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- FIDRAVVQGKNYQK-UHFFFAOYSA-N 1,2,3,4-tetrahydrotriazine Chemical compound C1NNNC=C1 FIDRAVVQGKNYQK-UHFFFAOYSA-N 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- -1 methanol and ethanol Chemical compound 0.000 description 9
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 238000001953 recrystallisation Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Natural products CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 230000026030 halogenation Effects 0.000 description 5
- 238000005658 halogenation reaction Methods 0.000 description 5
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 150000007522 mineralic acids Chemical class 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 230000002140 halogenating effect Effects 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- AAYCPBAOUJRPIC-UHFFFAOYSA-N 1-(diaminomethylidene)-2-methylguanidine;hydrochloride Chemical compound [Cl-].C[NH2+]\C(N)=N\C(N)=N AAYCPBAOUJRPIC-UHFFFAOYSA-N 0.000 description 1
- FKPUYTAEIPNGRM-UHFFFAOYSA-N 1-(diaminomethylidene)guanidine;hydron;chloride Chemical compound [Cl-].N\C([NH3+])=N/C(N)=N FKPUYTAEIPNGRM-UHFFFAOYSA-N 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical group COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- GHVZOJONCUEWAV-UHFFFAOYSA-N [K].CCO Chemical compound [K].CCO GHVZOJONCUEWAV-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical group 0.000 description 1
- 231100000369 acute toxicity data Toxicity 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- YOUGRGFIHBUKRS-UHFFFAOYSA-N benzyl(trimethyl)azanium Chemical class C[N+](C)(C)CC1=CC=CC=C1 YOUGRGFIHBUKRS-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000004997 halocarbonyl group Chemical group 0.000 description 1
- 150000002366 halogen compounds Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- ORAKNQSHWMHCEY-UHFFFAOYSA-N methyl 2-pyridin-2-ylacetate Chemical compound COC(=O)CC1=CC=CC=N1 ORAKNQSHWMHCEY-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- HSPSCWZIJWKZKD-UHFFFAOYSA-N n-chloroacetamide Chemical compound CC(=O)NCl HSPSCWZIJWKZKD-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Analogifremgangsraåte for fremstilling av nye triazinderivater. Analogy process for the production of new triazine derivatives.
Nærværende oppfinnelse vedrorer en fremgangsmåte for fremstilling av nye triazinderivater med hypotensiv og/eller diuretisk virkning. The present invention relates to a method for the production of new triazine derivatives with hypotensive and/or diuretic action.
Fremgangsmåten for fremstilling av et triazin-derivat med den generelle formel hvor hver av R^ og R^, som kan være samme eller forskjellige, er et hydrogenatom eller et C-^g alkyl-, C1+_r7 cykloalkyl-, allyl-, f enyl- eller benzylgruppe eller sammen med nitrogenatomet, til hvilket de er bundet, danner en usubstituert 5-8 leddet heterocyklisk ring som ved siden av nitrogenatomet bare inneholder karbonatomer eller karbonatoroer og et ringoksygen-atom eller et annet ringnitrogen-atom; The process for the preparation of a triazine derivative of the general formula where each of R^ and R^, which may be the same or different, is a hydrogen atom or a C-^g alkyl-, C1+_r7 cycloalkyl-, allyl-, f enyl or benzyl group or, together with the nitrogen atom to which they are attached, form an unsubstituted 5-8 membered heterocyclic ring which, next to the nitrogen atom, only contains carbon atoms or carbonatoroes and a ring oxygen atom or another ring nitrogen atom;
Rg og Ry sammen med nitrogenatomet, til hvilket de er bundet, danner en heterosyklisk ring som foran angitt; og Rg and Ry together with the nitrogen atom to which they are attached form a heterocyclic ring as indicated above; and
R^ er en usubstituert fenyl- eller pyridylgruppe5R 1 is an unsubstituted phenyl or pyridyl group 5
eller et syreaddisjonssalt av denne, karakteriseres ved at en forbindelse med den generelle formel II: or an acid addition salt thereof, is characterized in that a compound of the general formula II:
hvor X er et halogenatom og R^, R^ og R^ er som foran where X is a halogen atom and R^, R^ and R^ are as before
definert, defined,
omsettes på i og for seg kjent måte i et inert opplosningsmiddel, for eksempel etanol eller metyl-cellosolve, med et amin for formelen RgR^NH, hvor Rg og R^ er som foran definert. is reacted in a manner known per se in an inert solvent, for example ethanol or methyl cellosolve, with an amine of the formula RgR^NH, where Rg and R^ are as defined above.
Forbindelsene med den generelle formel 1 kan oppnås ved å bringe forbindelsen med formel II i kontakt med aminet i et inert organisk løsningsmiddel i nærvær eller fravær av en base. Reaksjonen kan utfores ved romstemperatur eller lavere, men vanligvis er temperaturer på 25 - 150°C foretrukket. The compounds of general formula 1 can be obtained by contacting the compound of formula II with the amine in an inert organic solvent in the presence or absence of a base. The reaction can be carried out at room temperature or lower, but usually temperatures of 25 - 150°C are preferred.
Brukbare løsningsmidler er f.eks. lavere alkoholer, slike som metanol, etanol, n-propanol, isopropanol, n-butanol, sekundær butanol og tertiær butanol; hydrokarboner slike som benzen, toluen, xylener, cykloheksan, petroleter og -bensiner; etere slike som eter, metyletyleter, dioheksan og tetrahydrofuran; ketoner slike som aceton, metyletylketon og dietylketon; og metylcellosolv. Etanol og metylcellosolv er spesielt foretrukne løsningsmidler. Usable solvents are e.g. lower alcohols, such as methanol, ethanol, n-propanol, isopropanol, n-butanol, secondary butanol and tertiary butanol; hydrocarbons such as benzene, toluene, xylenes, cyclohexane, petroleum ethers and benzines; ethers such as ether, methyl ethyl ether, diohexane and tetrahydrofuran; ketones such as acetone, methyl ethyl ketone and diethyl ketone; and methyl cellosolv. Ethanol and methylcellosolv are particularly preferred solvents.
Om onsket kan reaksjonen utfores i nærvær av en base slik som en uorganisk base, f.eks. alkalikarbonater og kaliumkarbonat og alkalihydroksyder slike som natriumhydroksyd, kaliumhydroksyd og kalsiumhydroksyd eller organiske baser, f.eks. metallalkoholater, slike som natriummetylat, natriumetylat, kaliummetylat og kaliumetylat, alkaliamider slike som natriumamid og kalium-amid, tertiære aminer slike som trietylamin, dimetylanilin og pyridin og kvartæré ammoniumsalter slike som trimetylbenzyl-ammoniumsalt. De uorganiske baser, métallalkoholatene og de tertiære aminer brukes med særlig fordel. Det ér også fordel-aktig å bruke et overskudd av forbindelsen med formel II. If desired, the reaction can be carried out in the presence of a base such as an inorganic base, e.g. alkali carbonates and potassium carbonate and alkali hydroxides such as sodium hydroxide, potassium hydroxide and calcium hydroxide or organic bases, e.g. metal alcoholates such as sodium methylate, sodium ethylate, potassium methylate and potassium ethylate, alkali amides such as sodium amide and potassium amide, tertiary amines such as triethylamine, dimethylaniline and pyridine and quaternary ammonium salts such as trimethylbenzyl ammonium salt. The inorganic bases, the metal alcoholates and the tertiary amines are used with particular advantage. It is also advantageous to use an excess of the compound of formula II.
Ingen spesiell innskrenkning er nødvendig når det gjelder reaksjonstiden. Vanligvis er reaksjonstiden 5 til 70 timer ved romstemperatur og fra 15 minutter til 15 timer ved losningsmidlets kokepunkt ved tilbakelop. Molforholdet mellom forbindelsen med formel 11 og aminet er vanligvis 1:1, men kan variere fra 1:0,5 til 1:5- Som nevnt foran, er det foretrukket å bruke et overskudd , f.eks. 1,1 til 3 mol. No special restriction is necessary regarding the reaction time. Generally, the reaction time is 5 to 70 hours at room temperature and from 15 minutes to 15 hours at the reflux boiling point of the solvent. The molar ratio between the compound of formula 11 and the amine is usually 1:1, but can vary from 1:0.5 to 1:5- As mentioned above, it is preferred to use an excess, e.g. 1.1 to 3 moles.
Mengden løsningsmiddel er heller ikke spesielt innskrenket, og det er tilstrekkelig at reaksjonssystemet blir opplost. Det brukes imidlertid vanligvis 3 til <*>+o, fortrinnsvis 5 til 25 ganger vekten av forbindelsen med formel 11. Når det brukes en base i reaksjonen, er mengden løsningsmiddel 0,5-3 mol, fortrinnsvis 1-1,5 mol, pr. mol av forbindelsen med formel 11, men mengden varierer med valg av base, reaksjonstemperatur og -tid og andre faktorer. The amount of solvent is not particularly limited either, and it is sufficient that the reaction system is dissolved. However, it is usually used 3 to <*>+o, preferably 5 to 25 times the weight of the compound of formula 11. When a base is used in the reaction, the amount of solvent is 0.5-3 mol, preferably 1-1.5 mol, per moles of the compound of formula 11, but the amount varies with choice of base, reaction temperature and time and other factors.
De 1, 3? 5 - triaziner som fås ved oppfinnelsen, er basiske forbindelser, og de kan overfores til de tilsvarende salter ved reak-sjon med uorganiske eller organiske syrer. Overforingen kan lett utfores ved å lose opp forbindelsen med formel 1 i et passende opplbsningsmiddel, f.eks. en alkohol slik som metanol og etanol, et hydrokarbon slik som benzen og toluen, et keton slik som aceton og metyletylketon og et acetat, deretter å tilsette en beregnet mengde eller et lite overskudd av en uorganisk eller organisk syre til oppløsningen og derpå fjerne opplosningsmidlet ved destillasjon. Det foretrekkes å rense saltene ved omkrystallisering fra et passende løsningsmiddel, f.eks. en alkohol slik som metanol og etanol, et keton slik som aceton eller metyletylketon, en eter som etyleter og dioksan, et hydrokarbon slik som benzen og toluen, dimetylformamid eller en blanding av disse. The 1, 3? 5 - triazines obtained by the invention are basic compounds, and they can be converted to the corresponding salts by reaction with inorganic or organic acids. The transfer can easily be carried out by dissolving the compound of formula 1 in a suitable solvent, e.g. an alcohol such as methanol and ethanol, a hydrocarbon such as benzene and toluene, a ketone such as acetone and methyl ethyl ketone and an acetate, then adding a calculated amount or a small excess of an inorganic or organic acid to the solution and then removing the solvent by distillation. It is preferred to purify the salts by recrystallization from a suitable solvent, e.g. an alcohol such as methanol and ethanol, a ketone such as acetone or methyl ethyl ketone, an ether such as ethyl ether and dioxane, a hydrocarbon such as benzene and toluene, dimethylformamide or a mixture thereof.
Som slike syrer kan det nevnes uorganiske syrer som saltsyre, hydrobromsyre, svovelsyre, salpetersyre, fosforsyre og hydrojod-syre, og organiske syrer, f.eks. alifatiske monokarboksylsyrer slike som eddiksyre og propionsyre, alifatiske dikarboksylsyrer slike som malonsyre, ravsyre, maleinsyre og fumarsyre, oksysyrer slike som glykolsyre, malinsyre, vinmandelsyre, salisylsyre og ftalsyre, sulfonsyrer slike som metansulfonsyre og benzensulfon-syre og nikotinsyre. Such acids include inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid and hydroiodic acid, and organic acids, e.g. aliphatic monocarboxylic acids such as acetic acid and propionic acid, aliphatic dicarboxylic acids such as malonic acid, succinic acid, maleic acid and fumaric acid, oxyacids such as glycolic acid, malic acid, tartarmandelic acid, salicylic acid and phthalic acid, sulphonic acids such as methanesulphonic acid and benzenesulphonic acid and nicotinic acid.
Eksempler på flerleddede ringer dannet av noen av kombinasjonene R- og R^ eller R^ og R^ er som folger: Examples of multi-membered rings formed by some of the combinations R- and R^ or R^ and R^ are as follows:
Flerleddede ringer bundet med metylen slike som Multi-membered rings bonded with the methylene such as
Flerleddede ringer bundet med metylen over et oksygenatom, slik som Flerleddede ringer bundet med metylen over et nitrogenatom, slik som Multi-membered rings bonded with the methylene over an oxygen atom, such as Multi-membered rings bonded with the methylene over a nitrogen atom, such as
Forbindelsene med formel II kan fremstilles ved å omsette en forbindelse med fblgende formel III: The compounds of formula II can be prepared by reacting a compound of the following formula III:
hvor Rn 7 er en karboksyl-, alkoksykarbonyl- eller halogenkarbonylgruppe, en syreanhydridrest eller en cyanogruppe, where Rn 7 is a carboxyl, alkoxycarbonyl or halocarbonyl group, an acid anhydride residue or a cyano group,
R^ har samme betydning som i formel 1 og Q er et hydrogen-eller halogenatom, med en forbindelse med folgende formel IV: R^ has the same meaning as in formula 1 and Q is a hydrogen or halogen atom, with a compound of the following formula IV:
hvor R^ og R^ har de samme betydninger som angitt where R^ and R^ have the same meanings as indicated
under formel I, under Formula I,
eller deres sure salter, fortrinnsvis salter av uorganiske syrer i nærvær av et inert løsningsmiddel. Reaksjonen fortsetter om forbindelsene III og IV kontaktes med hverandre i nevnte løsningsmiddel. Reaksjonen kan utfores i nærvær eller fravær av en base slik som nevnt ovenfor i forbindelse med reaksjonen av forbindelsen med formel II cg aminet. Foretrukne baser er metallalkoholater og alkalihydroksyder. De samme løsningsmidler som nevnt ovenfor kan også brukes. Disse løsningsmidler kan inneholde vann. or their acid salts, preferably salts of inorganic acids in the presence of an inert solvent. The reaction continues if the compounds III and IV are contacted with each other in said solvent. The reaction can be carried out in the presence or absence of a base as mentioned above in connection with the reaction of the compound of formula II and the amine. Preferred bases are metal alcoholates and alkali hydroxides. The same solvents as mentioned above can also be used. These solvents may contain water.
Ingen spesielle innskrenkninger gjores når det gjelder reaksjonstid og -temperatur. Brukbare temperaturer er romstemperatur til 2Q0°C, og tilstrekkelig reaksjonstid 2 til 100 timer. No special restrictions are made regarding reaction time and temperature. Usable temperatures are room temperature to 2Q0°C, and sufficient reaction time 2 to 100 hours.
Om Q i formel III er et hydrogenatom, oppnås folgende forbindelse If Q in formula III is a hydrogen atom, the following compound is obtained
hvor R^5 R^ og R^ har samme betydning som i formel 1. where R^5 R^ and R^ have the same meaning as in formula 1.
I dette tilfelle vil halogenering gi en forbindelse med formelen II. Halogeneringen kan lett utfores ved å behandle forbindelsen med formel II' med et halogeneringsmiddel slik som klor, brom, N-halogenimid f.eks. N-bromravsyreimid og N-kloracetamid i nærvær av et inert organisk løsningsmiddel. Eksempler på løsningsmidler til bruk ved halogeneringen er karbondisulfid, In this case, halogenation will give a compound of formula II. The halogenation can be easily carried out by treating the compound of formula II' with a halogenating agent such as chlorine, bromine, N-halogenimide, e.g. N-bromosuccinimide and N-chloroacetamide in the presence of an inert organic solvent. Examples of solvents for use in the halogenation are carbon disulphide,
en alkohol slik som metanol og etanol, halogenerte hydrokarboner slike som- kloroform, karbontetraklorid og dikloretan og lavere alifatiske syrer slike som eddiksyre og vandig eddiksyre. Reaksjonstemperaturen er ikke spesielt kritisk, men varierer beroende på hvilket løsningsmiddel som brukes. F.eks. kan en temperatur i området -5 til +150°C brukes. Sluttproduktet kan utskilles på vanlig måte. an alcohol such as methanol and ethanol, halogenated hydrocarbons such as chloroform, carbon tetrachloride and dichloroethane and lower aliphatic acids such as acetic acid and aqueous acetic acid. The reaction temperature is not particularly critical, but varies depending on the solvent used. E.g. a temperature in the range -5 to +150°C can be used. The end product can be separated in the usual way.
Aminene er kjente forbindelser og kan fremstilles etter enhver kjent fremgangsmåte. Forbindelsene med formel III der Q er et hydrogenatom, er også kjente forbindelser og kan fremstilles ved kjente fremgangsmåter. Forbindelser med formel III der Q er en halogenforbindelse, kan lett fremstilles ved halogenering av forbindelse III.der Q er et hydrogenatom under samme betingelser og med samme løsningsmiddel og halogeneringsmiddel som ved halogeneringen ovenfor. Forbindelsene med formel IV kan også fremstilles ved en kjent metode (f.eks. J.Am.Chem.Soc. 81, 3725", 1959) eller en lignende fremgangsmåte. The amines are known compounds and can be prepared according to any known method. The compounds of formula III where Q is a hydrogen atom are also known compounds and can be prepared by known methods. Compounds of formula III where Q is a halogen compound can be easily prepared by halogenation of compound III where Q is a hydrogen atom under the same conditions and with the same solvent and halogenating agent as in the halogenation above. The compounds of formula IV can also be prepared by a known method (eg J.Am.Chem.Soc. 81, 3725", 1959) or a similar method.
Fremgangsmåten ifolge oppfinnelsen som er beskrevet ovenfor i detalj, vil bli vist skjematisk i det folgende, inkludert fremgangsmåten til fremstilling av utgangsforbindelsen med formel II. The method according to the invention, which is described above in detail, will be shown schematically in the following, including the method for preparing the starting compound of formula II.
Forbindelsen med formel I, som resulterer fra reaksjonen mellom forbindelsen med formel 11 og aminet kan renses ved en fremgangsmåte som omfatter å fjerne losningsmidlet ved destillasjon, tilsetning av vann og deretter alkali slik som alkalikarbonat, og så å ekstrahere forbindelsen med formel 1 fra blandingen ved bruk av et med vann ikke-blandbart opplosningsmiddel slik som kloroform, metylenklorid og etylacetat, torking på vanlig måte, fjerning av losningsmidlet og omkrystallisering fra et passende løsnings-middel, f.eks. lavere alkoholer slike som metanol og etanol, blandingen av vann og alkohol, ketoner slike som aceton og metyletylketon, acetat og halogenerte hydrokarboner slike som kloroform og metylenklorid. Om bnsket kan produktet renses ved væske-kromatografering ved bruk av en aluminiumoksyd- eller silikagel-kolonne og omkrystallisering av eluatet. The compound of formula I resulting from the reaction between the compound of formula 11 and the amine can be purified by a process comprising removing the solvent by distillation, adding water and then alkali such as alkali carbonate, and then extracting the compound of formula 1 from the mixture by use of a water-immiscible solvent such as chloroform, methylene chloride and ethyl acetate, drying in the usual manner, removal of the solvent and recrystallization from a suitable solvent, e.g. lower alcohols such as methanol and ethanol, the mixture of water and alcohol, ketones such as acetone and methyl ethyl ketone, acetate and halogenated hydrocarbons such as chloroform and methylene chloride. If desired, the product can be purified by liquid chromatography using an alumina or silica gel column and recrystallization of the eluate.
Tabell 1 viser den hypotensive aktivitet for flere typiske forbindelser ifdlge oppfinnelsen sammen med akutte toksisitetsdata (<LD>50). Table 1 shows the hypotensive activity for several typical compounds according to the invention together with acute toxicity data (<LD>50).
Disse forbindelser er som folger (Referansetabellene tilsvarer de som forekommer i tabellene 1, 11, 111 og IV): (1) 2-amino-1^-mo^folino-6-(2, -pyridyl-morfolinometyl)-l>3»5-triazin These compounds are as follows (The reference tables correspond to those appearing in Tables 1, 11, 111 and IV): (1) 2-amino-1^-morpholino-6-(2, -pyridyl-morpholinomethyl)-l>3 »5-triazine
(2) 2,*t-diamino-6- (21-pyridyl-morfolinometyl)-1,3,5-triazin (2) 2,*t-diamino-6-(21-pyridyl-morpholinomethyl)-1,3,5-triazine
(3) 2-amino-1+-metylamino-6-(2' -pyridyl-morfolinometyl)-l>3»5-triazin ( k) 2-amino-l+-dimetylamino-6- (21 -pyridyl-morfolinometyl)-1j 3» 5-triazin (5) 2-araino-lf-diallylamino-6-(2' -pyridyl-morfolinometyl) 1? 3» 5-triazin (6) 2-amino-<1>f-N-metylanilino-6-(2'-pyridylmetyl)-l,3,5-triazin (3) 2-amino-1+-methylamino-6-(2'-pyridyl-morpholinomethyl)-1>3»5-triazine (k) 2-amino-1+-dimethylamino-6-(21-pyridyl-morpholinomethyl)-1j 3» 5-triazine (5) 2-araino-1+-diallylamino-6-(2'-pyridyl-morpholinomethyl) 1? 3»5-triazine (6) 2-amino-<1>f-N-methylanilino-6-(2'-pyridylmethyl)-1,3,5-triazine
(7) 2-amino-lf-piperidino-6-(2l<->pyridylmetyl)-l,3,5-triazin (7) 2-amino-1f-piperidino-6-(2l<->pyridylmethyl)-1,3,5-triazine
(8) 2-amino-lf-morfolino-6-(2'-pyridylpiperidino)-l,3,5-triazin (9) 2-amino-lf-morfolino-6-(2l<->pyridyl-N-azacykloheptylmetyl)-1,3,5-trlazin ( lk) 2-amino-l*-dimetylamino-6- (f enylmorf olinometyl) -1,3,5-triazin (21) 2-amino-1+-etylamino-6- (2' -pyridylmorf olinometyl)-1,3,5-triazin (23) 2-amino-<1>+-allylamino-6-(2'-pyridylmorfolinometyl)-1,3,5-triazin ( 2k) 2-amino-lf-dietylamino-6-(2' -pyridylmorf olinometyl3,5-triazin (25) 2-amino-6-benzylamino-6-(2'-pyridyl-morfolinometyl)-1,3,;-triazin (26) 2-amino-1+-pyrrolidino-6-(2l -pyridylmorf olinometyl)-1,3, 5-triazin (36) 2,V-di-monometylamino-6-(2'-pyridylmorfolinometyl)-1,3,5-triazin (^3) 2-amino-^-morfolino-6-(3<1->pyridylmorfolinometyl)-1,3,5-triazin (8) 2-amino-1f-morpholino-6-(2'-pyridylpiperidino)-1,3,5-triazine (9) 2-amino-1f-morpholino-6-(2l<->pyridyl-N-azacycloheptylmethyl )-1,3,5-trlazine ( lk ) 2-amino-1*-dimethylamino-6-(phenylmorpholinomethyl)-1,3,5-triazine (21) 2-amino-1+-ethylamino-6-(2'-pyridylmorpholinomethyl)-1 ,3,5-triazine (23) 2-amino-<1>+-allylamino-6-(2'-pyridylmorpholinomethyl)-1,3,5-triazine ( 2k ) 2-amino-1f-diethylamino-6-(2'-pyridylmorpholinomethyl3,5-triazine (25) 2-amino-6-benzylamino-6-(2'-pyridylmorpholinomethyl)-1,3,; -triazine (26) 2-amino-1+-pyrrolidino-6-(2l -pyridylmorpholinomethyl)-1,3,5-triazine (36) 2,V-di-monomethylamino-6-(2'-pyridylmorpholinomethyl)- 1,3,5-triazine (^3) 2-amino-^-morpholino-6-(3<1->pyridylmorpholinomethyl)-1,3,5-triazine
Flere utforelser av fremgangsmåten ifolge oppfinnelsen skal gis nedenfor. Several embodiments of the method according to the invention will be given below.
Eksempel 1 Example 1
Fremstilling av forbindelse med formel 11. Preparation of compound of formula 11.
(1) N<1> ,N'-anhydro-bis(p-hydroksyetyl) biguanidhydroklorid (356g) ble suspendert i 15 ml. vannfri metanol. En natriummetylatlosning fremstilt fra 0,58 g natrium og 5»5 ml metanol ble tilsatt suspensjonen. Etter tilsetning av 5>3 g etyl-2-pyridyl-bromacetat (et eksempel på en forbindelse av formel V der Q er et halogenatom) ble den resulterende blanding hensatt ved romstemperatur i 72 timer. Etterfølgende tilsetning av vann gav utfellning av krystaller, som ble frafiltrert og omkrystallisert fra etanol. Det ble oppnådd 1,3 g (21 % utbytte) av 2-amino-1+-morfolino-6-(2'-pyridyl-brommetyl)-l,3,5-triazin med et smeltepunkt på 155-156°C (dekomponering). (1) N<1> ,N'-anhydro-bis(p-hydroxyethyl) biguanide hydrochloride (356g) was suspended in 15 ml. anhydrous methanol. A sodium methylate solution prepared from 0.58 g sodium and 5.5 ml methanol was added to the suspension. After addition of 5>3 g of ethyl 2-pyridyl bromoacetate (an example of a compound of formula V where Q is a halogen atom) the resulting mixture was allowed to stand at room temperature for 72 hours. Subsequent addition of water precipitated crystals, which were filtered off and recrystallized from ethanol. 1.3 g (21% yield) of 2-amino-1+-morpholino-6-(2'-pyridyl-bromomethyl)-1,3,5-triazine with a melting point of 155-156°C ( decomposition).
Analytiske data for C23H1 5N60Br er som folger: Analytical data for C23H1 5N60Br are as follows:
(2) Forbindelsen med formel 11 kan også fremstilles ved folgende fremgangsmåte med bruk av forbindelsen med formel III der Q er et hydrogenatom. (2) The compound of formula 11 can also be prepared by the following method using the compound of formula III where Q is a hydrogen atom.
N<1>,N<1->anhydro-bis(p-hydroksyetyl)-biguanidhydroklorid (1,05 g) ble satt til en natriummetylatlosning fremstilt fra 0,172 g natrium og 7 ml vannfri metanol, og ved tilstning av 1,0 g 2-pyri-dylacetetylester ble blandingen omsatt i 20 timer ved romstemperatur. Etterfølgende tilsetning av vann gav utfellning av krystaller som ble frafiltrert og omkrystallisert fra metanol. Det ble oppnådd 0,78 g (W3 # utbytte) av 2-amino-1t-morfolino-6-(2'-pyridylmetyl)-l,3,5-triazin med et smeltepunkt på m-8-1^9°C. N<1>,N<1->anhydro-bis(p-hydroxyethyl)-biguanide hydrochloride (1.05 g) was added to a sodium methylate solution prepared from 0.172 g of sodium and 7 ml of anhydrous methanol, and by adding 1.0 g 2-pyridylacetyl ester, the mixture was reacted for 20 hours at room temperature. Subsequent addition of water precipitated crystals which were filtered off and recrystallized from methanol. 0.78 g (W3 # yield) of 2-amino-1t-morpholino-6-(2'-pyridylmethyl)-1,3,5-triazine with a melting point of m-8-1^9°C was obtained .
Analytiske data for C-j^H-j^NgO var som f Siger i Analytical data for C-j^H-j^NgO were as f Says i
De overfor oppnådde 2-amino-<1>*-morfolino-6-(2'-pyridylmetyl)-;1,3,5-triazin ble opplQst i 2o ml kloroform. Mens lesningen ble kjolt med is til en temperatur under 0°C, ble en lbsning av 0,8 g brom i 3 ml kloroform tildryppet. Blandingen ble omrort i 30 minutter ved samme temperatur, og kloroformen ble avdestillert. Resten ble opplbst i vann og gjort alkalisk med natriumkarbonat. De utfelte krystaller ble omkrystallisert fra etanol og gav 1,16 g (68 # utbytte) 2-amino-lf-morfollno-6-(2' -pyridylbrommetyl)-1,3,5-triazin som hadde et smeltepunkt på 155-156°C (dekomponering). The 2-amino-<1>*-morpholino-6-(2'-pyridylmethyl)-1,3,5-triazine obtained above were dissolved in 20 ml of chloroform. While the reading was cooled with ice to a temperature below 0°C, a solution of 0.8 g of bromine in 3 ml of chloroform was added dropwise. The mixture was stirred for 30 minutes at the same temperature, and the chloroform was distilled off. The residue was dissolved in water and made alkaline with sodium carbonate. The precipitated crystals were recrystallized from ethanol to give 1.16 g (68 # yield) of 2-amino-1f-morpholno-6-(2'-pyridylbromomethyl)-1,3,5-triazine having a melting point of 155-156 °C (decomposition).
Analytiske data for C^H^N^OBr er som fblger: Analytical data for C^H^N^OBr are as follows:
Fremstilling av forbindelsen med formel 1: 2-amino-^-morfolino-6-(21-pyridyl-brommetyl)-1,3,5-triazin oppnådd i (1) eller (2) ovenfor (5,0 g) og 2,5 g morfolin ble satt til 50 ml etanol. Blandingen ble oppvarmet ved tilbakelbp i 5 timer jog etanolen ble avdestillert. Vann ble tilsatt til resten og blandingen ble gjort alkalisk med natriumkarbonat, fulgt av ekstråk-jsjon med kloroform. Ekstrakten ble torket over natriumsulfat og jkloroform fjernet ved destillasjon. Resten ble omkrystallisert fra etanol og gav 2,7 g (53 % utbytte) 2-amlno-l*~morfolino-6-j(2'-pyridyl-morfolinometyl)-l,3,5-triazin med et smeltepunkt på 178-180°C. Preparation of the compound of formula 1: 2-amino-^-morpholino-6-(21-pyridyl-bromomethyl)-1,3,5-triazine obtained in (1) or (2) above (5.0 g) and 2 .5 g of morpholine was added to 50 ml of ethanol. The mixture was heated at reflux for 5 hours and the ethanol was distilled off. Water was added to the residue and the mixture was made alkaline with sodium carbonate, followed by extraction with chloroform. The extract was dried over sodium sulfate and chloroform removed by distillation. The residue was recrystallized from ethanol to give 2.7 g (53% yield) of 2-amino-1*-morpholino-6-j-(2'-pyridyl-morpholinomethyl)-1,3,5-triazine with a melting point of 178- 180°C.
Analytiske data for Cjr,H2^Nr,02 er som fblger: Analytical data for Cjr,H2^Nr,02 are as follows:
jDet oppnådde 2-amino-<1>t-morfolino-6-(2'-pyridyl-morfolinometyl)-l>3»5-triazin ble opplost i etanol. En beregnet mengde N-svovelsyre ble tilsatt til lbsningen. Losningsmidlet ble fjernet ved destillasjon under redusert trykk. Omkrystallisering av resten f fra etanol gav et sulfat av 2-amino-lt-morfolino-6-(21 -pyridylmorf olinometyl)-1,3»5-triazin med et dekomponeringspunkt på |217-219°C. The obtained 2-amino-<1>t-morpholino-6-(2'-pyridyl-morpholinomethyl)-1>3»5-triazine was dissolved in ethanol. A calculated amount of N-sulfuric acid was added to the solution. The solvent was removed by distillation under reduced pressure. Recrystallization of the residue f from ethanol gave a sulfate of 2-amino-1-morpholino-6-(21-pyridylmorpholinomethyl)-1,3»5-triazine with a decomposition point of |217-219°C.
i in
i Eksempler 2- Mh in Examples 2- Mh
På samme måte som i eksempel 1 ble forbindelsene med formel 11 fremstilt og ble omsatt med aminene med formel 111. Reaksjons-<;>betingelsene og de oppnådde forbindelser med forme]. 1 er vist i tabellene 11 og 111. Reaksjonstemperaturen var tilbakelbpstemp-eraturen for det brukte løsningsmiddel eller romstemperatur. Tabell IV viser fremstillingen av forbindelsene med formel 11 som |er angitt i tabell 11. In the same way as in Example 1, the compounds of formula 11 were prepared and were reacted with the amines of formula 111. The reaction conditions and the obtained compounds of formula]. 1 is shown in Tables 11 and 111. The reaction temperature was the return temperature of the solvent used or room temperature. Table IV shows the preparation of the compounds of formula 11 which are indicated in Table 11.
i in
De folgende forbindelser ble oppnådd på liknende måte The following compounds were obtained in a similar manner
Eksempel >+5 Example >+5
Fremstilling av forbindelsen med formel 11. Preparation of the compound of formula 11.
(1) N'-metylbiguanidhydroklorid (1 5,0 g) ble tilsatt til en natriummetylatlosning fremstilt fra 3,67 g natrium ig 1^0 ml vannfri metanol. Ved tilstning av 19,5 g etyl-2-pyridyl-bromacetat ble blandingen behandlet på samme måte som i eksempel 1. Omkrystallisering fra etanol gav 5»2 g (21,7 % utbytte) 2-amino-^-metylamino-6-(2<*->pyridylbrommetyl)-l,3,5-triazin med smeltepunkt på 16<*>+ - 165°C (dekomponering). (1) N'-methylbiguanide hydrochloride (15.0 g) was added to a sodium methylate solution prepared from 3.67 g of sodium in 1^0 ml of anhydrous methanol. By adding 19.5 g of ethyl 2-pyridyl bromoacetate, the mixture was treated in the same way as in example 1. Recrystallization from ethanol gave 5.2 g (21.7% yield) of 2-amino-^-methylamino-6- (2<*->pyridylbromomethyl)-1,3,5-triazine with a melting point of 16<*>+ - 165°C (decomposition).
De analytiske data for Cj qK^1N^Br er som folger: The analytical data for Cj qK^1N^Br are as follows:
(2) N<*->metylbiguaniddihydroklorid (3,76 g) ble suspendert i 5ml metanol og 11,5 ml 10 %- ig natriummetylatlosning og 3»33 g metyl-2-pyrldylasetat ble tilsatt til suspensjonen. Blandingen ble behandlet på samme måte som i eksempel 1. Omkrystallisering fra metanol gav 0,88 g (20,3 %. utbytte) 2-amino-lf-metylamino-6-2'-pyridylmetyl)-1,3,5-triazin. (2) N<*->methylbiguanide dihydrochloride (3.76 g) was suspended in 5 ml of methanol and 11.5 ml of 10% sodium methylate solution and 3.33 g of methyl 2-pyridyl acetate were added to the suspension. The mixture was treated in the same manner as in Example 1. Recrystallization from methanol gave 0.88 g (20.3% yield) of 2-amino-1f-methylamino-6-2'-pyridylmethyl)-1,3,5-triazine .
De analytiske data for C, QH12ND er som folger: The analytical data for C, QH12ND are as follows:
Det ovenfor oppnådde 2-amino-^—metylamino-6-(2, -pyridylmetyl)-1,3,5-triazin ble bromert på samme måte som i eksempel 1. De utfelte krystaller ble omkrystallisert fra etanol og gav 2-amino-^-metylamino-6-(2<*->pyridyl-brommetyl)-l,3,5-triazin med smeltepunkt på lSk - 165°C (dekomponering). The 2-amino-^-methylamino-6-(2,-pyridylmethyl)-1,3,5-triazine obtained above was brominated in the same manner as in Example 1. The precipitated crystals were recrystallized from ethanol and gave 2-amino- ^-Methylamino-6-(2<*->pyridyl-bromomethyl)-1,3,5-triazine with a melting point of 1Sk - 165°C (decomposition).
De analytiske data for C^H^N^Br er som folger: The analytical data for C^H^N^Br are as follows:
Fremstilling av forbindelsen med formel 1: Preparation of the compound of formula 1:
Til 30 ml etanol ble tilsatt 1,2 g 2-amino-lf-metylamino-6-(2<1->pyridylbrommetyl)-l,3,5-triazin og 0,7 g morfolin og blandingen ble oppvarmet i 5 timer ved tilbakelop. Behandlingen ble utfort som i eksempel 1. Påfolgende omkrystallisering fra etylacetat gav 0,6 g (^8,5 % utbytte) krystaller med et smeltepunkt på 17I+ - 175°C. Det oppnådde produkt ble overfort til sulfatet ved en vanlig metode og omkrystallisert fra metanol. Det ble oppnådd 2^amino-lt-metylamino-6-(2'-pyridyl-morfolinometyl)-1,3>5-triazinsulfat med et dekomponeringspunkt på 218 - 219°C. To 30 ml of ethanol was added 1.2 g of 2-amino-1f-methylamino-6-(2<1->pyridylbromomethyl)-1,3,5-triazine and 0.7 g of morpholine and the mixture was heated for 5 hours at backflow. The treatment was carried out as in example 1. Subsequent recrystallization from ethyl acetate gave 0.6 g (8.5% yield) of crystals with a melting point of 17I+ - 175°C. The product obtained was transferred to the sulfate by a conventional method and recrystallized from methanol. 2-Amino-1-methylamino-6-(2'-pyridyl-morpholinomethyl)-1,3>5-triazine sulfate was obtained with a decomposition point of 218-219°C.
De analytiske data for C^H^N^O'B^SO^ er som folger: The analytical data for C^H^N^O'B^SO^ are as follows:
Claims (1)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4631867A JPS457059B1 (en) | 1967-07-20 | 1967-07-20 | |
| JP5832567 | 1967-09-13 | ||
| JP2096568 | 1968-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO126272B true NO126272B (en) | 1973-01-15 |
Family
ID=27283238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO02833/68A NO126272B (en) | 1967-07-20 | 1968-07-17 |
Country Status (3)
| Country | Link |
|---|---|
| ES (1) | ES356288A1 (en) |
| NO (1) | NO126272B (en) |
| SE (1) | SE351648B (en) |
-
1968
- 1968-07-17 NO NO02833/68A patent/NO126272B/no unknown
- 1968-07-19 ES ES356288A patent/ES356288A1/en not_active Expired
- 1968-07-19 SE SE09917/68A patent/SE351648B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES356288A1 (en) | 1970-04-01 |
| SE351648B (en) | 1972-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0548532B1 (en) | 5,6-Disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5-(substituted methyl)-2,3-pyridinedicarboxylic acids | |
| NO144514B (en) | HANDLING FOR HOUSEHOLD AND GARDEN EQUIPMENT | |
| NO163816B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE PIPERAZINE DERIVATIVES. | |
| HK1001055B (en) | 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5-(substituted methyl)-2,3-pyridinedicarboxylic acids | |
| MX2008008447A (en) | Process for the preparation of imatinib. | |
| PL94155B1 (en) | ||
| NO822949L (en) | PROCEDURE FOR THE PREPARATION OF ANILID DERIVATIVES. | |
| Reiter et al. | On triazoles. V. Synthesis of 1‐and 2‐R1‐3‐R2, R3‐amino‐5‐amino‐1, 2, 4‐triazoles | |
| NO140011B (en) | 6-SUBSTITUTED-4-HALOGEN-1,2-DIHYDRO-1-HYDROXY-2-IMINOPYRIMIDINES FOR USE IN THE PREPARATION OF THE CORRESPONDING 4-AMINO COMPOUNDS | |
| NO157699B (en) | PROCEDURE FOR THE PREPARATION OF KINOLIN CARBOXYLIC ACID DERIVATIVES. | |
| US2979508A (en) | Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols | |
| HU223578B1 (en) | Process for the preparation of 0-[4-(4-heterocyclyl)alkyl]-tyrosine derivatives as fibrinogen receptor antagonists | |
| NO764039L (en) | ||
| JPS61115073A (en) | Production of 2, 2'-methylenebis(4-substituted-6 benzotriazolylphenzol | |
| NO126272B (en) | ||
| NO147838B (en) | INTERMEDIATE FOR USE IN PREPARATION OF THE HYPOTENSIVE AGENT 2- (4- (2-FUROYL) PIPERAZIN-1-YL) -4-AMINO-6,7-DIMETOXYKINAZOLINE | |
| US2621162A (en) | J-propargyl-x-quinazolones and acid | |
| AU2004323810B2 (en) | Novel intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole | |
| EP0233760A1 (en) | Sulfenamide derivatives and their production | |
| US2855398A (en) | Amidines of the indole series | |
| NO321357B1 (en) | Process for Preparation of 4- (heteroarylmethyl) -halo-1 (2H) -phthalazinones | |
| RU1838309C (en) | Method of synthesis of quinazoline derivatives or their pharmaceutically acceptable acid-additive salts | |
| US3551498A (en) | Dehydrogenation of 10,11-dihydro-5h-dibenzo(a,d)cycloheptene-5-one | |
| NO130329B (en) | ||
| SU999967A3 (en) | Process for producing 6-n-substituted 6-amino-3-pyridazinyl hydrizines or their salts |